Your browser doesn't support javascript.
loading
Inhibition of nitric oxide synthase causes cardiac phenotypic modulation in rat.
Takaori, K; Kim, S; Ohta, K; Hamaguchi, A; Yagi, K; Iwao, H.
Afiliação
  • Takaori K; Department of Health Science, Osaka Kyoiku University, Japan.
Eur J Pharmacol ; 322(1): 59-62, 1997 Mar 12.
Article em En | MEDLINE | ID: mdl-9088871
ABSTRACT
Cardiac gene expressions of collagen and contractile proteins were examined in rats treated with a nitric oxide (NO) synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME), for 3 weeks. The rats became hypertensive, which caused left ventricular hypertrophy. Among the mRNAs examined, beta-myosin heavy chain was increased and alpha-myosin heavy chain was decreased in both left and right ventricles, whereas skeletal alpha-actin and atrial natriuretic polypeptide were increased in the left ventricle only. Furthermore, coadministration of losartan with L-NAME lowered blood pressure and caused regression of left ventricular hypertrophy, but did not affect beta- and alpha-myosin heavy chain mRNA levels, indicating that L-NAME directly regulates beta- and alpha-myosin heavy chain mRNA.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Óxido Nítrico Sintase / NG-Nitroarginina Metil Éster / Inibidores Enzimáticos / Coração Idioma: En Ano de publicação: 1997 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Óxido Nítrico Sintase / NG-Nitroarginina Metil Éster / Inibidores Enzimáticos / Coração Idioma: En Ano de publicação: 1997 Tipo de documento: Article